GT Biopharma (GTBP) Short-Term Debt issuances (2011 - 2017)
GT Biopharma (GTBP) posted quarterly Short-Term Debt issuances of $4.9 million for Q3 2017, up 1261.88% year-over-year from $362000.0 in Q3 2016, and up 2428.21% quarter-over-quarter from $195000.0 in Q2 2017.
GT Biopharma (GTBP) Short-Term Debt issuances (2011 - 2017) Analysis & Trends
GT Biopharma (GTBP) has reported Short-Term Debt issuances for 7 consecutive years, with $4.9 million the latest figure, recorded in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | GT Biopharma | 8.64 Mn | 8.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 4.93 Mn |
| Sep 30, 2017 | 4.93 Mn |
| Jun 30, 2017 | 195,000.00 |
| Jun 30, 2017 | 195,000.00 |
| Mar 31, 2017 | 866,000.00 |
| Mar 31, 2017 | 866,000.00 |
| Sep 30, 2016 | 362,000.00 |
| Sep 30, 2016 | 362,000.00 |
| Jun 30, 2016 | 1.39 Mn |
| Jun 30, 2016 | 1.39 Mn |
| Mar 31, 2016 | 150,000.00 |
| Mar 31, 2016 | 150,000.00 |
| Sep 30, 2015 | 550,000.00 |
| Sep 30, 2015 | 550,000.00 |
| Mar 31, 2015 | 2.35 Mn |
| Mar 31, 2015 | 2.35 Mn |
| Sep 30, 2014 | 1.24 Mn |
| Sep 30, 2014 | 1.24 Mn |
| Jun 30, 2014 | 39,000.00 |
| Jun 30, 2014 | 39,000.00 |